Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of long-term results from a multicenter study evaluating the safety and ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Neurent Medical's NEUROMARK system for the treatment of individuals with chronic rhinitis. Comprising a single-use, handheld ...
Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the launch of its next-generation RhinAer® device as well as UnitedHealthcare’s Medicare ...
The Cigna Group CI recently announced that it will start covering RhinAer, a minimally invasive solution for chronic rhinitis, starting Sept. 15, 2025. This move highlights the increasing confidence ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced that Cigna Healthcare will provide coverage for ...
Please provide your email address to receive an email when new articles are posted on . In addition to asthma and rhinitis, deployed vs. non-deployed veterans had a significantly elevated risk for ...
9don MSN
Switch off your allergies for years without daily pills? Know the treatment backed by WHO and AAAAI
It can reduce symptoms, decrease the need for daily medication and lower future risk of asthma in some cases. In its resources for patients with allergic rhinitis and allergic asthma, the American ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback